0001753926-22-001525.txt : 20221205 0001753926-22-001525.hdr.sgml : 20221205 20221205080459 ACCESSION NUMBER: 0001753926-22-001525 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 EFFECTIVENESS DATE: 20221205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspargo Laboratories, Inc. CENTRAL INDEX KEY: 0001805092 IRS NUMBER: 843757833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466492 FILM NUMBER: 221443795 BUSINESS ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 201-408-4831 MAIL ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D 1 primary_doc.xml X0708 D LIVE 0001805092 Aspargo Laboratories, Inc. 550 SYLVAN AVENUE ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 2014084831 DELAWARE Virgatech Inc None Corporation true 2019 Michael Demurjian 61 Hubbard Avenue Red Bank NJ NEW JERSEY 07701 Executive Officer Michael Rice 155 Walnut Street Englewood NJ NEW JERSEY 07631 Director Fred Biehl 24 Tennyson Dr Short Hills Short Hills NJ NEW JERSEY 07078 Director Pharmaceuticals $1 - $1,000,000 06b false 2022-11-28 false true false 40000 Axiom Capital Management, Inc. 26580 Eric Miller None 350 FIFTH AVENUE, SUITE 6740 NEW YORK NY NEW YORK 10118 CA CALIFORNIA FL FLORIDA NV NEVADA NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA false Newbridge Securities Corporation 104065 Gene Abrams None 1200 NORTH FEDERAL HIGHWAY, SUITE 400 FL BOCA RATON FL FLORIDA 33432 CA CALIFORNIA FL FLORIDA NV NEVADA NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA false 15000000 290000 14710000 false 0 20300 0 0 false Aspargo Laboratories, Inc. /s/ Michael Demurjian Michael Demurjian Chairman & CEO 2022-12-05